Comment from The Association for Accessible Medicines (AAM)

Summary: The Association for Accessible Medicines (AAM), representing the generic pharmaceutical industry, supports the finalized guidance on investigating Out-of-Specification (OOS) test results. While they generally applaud the guidance, they request the reinstatement of a 2006 statement regarding the auxiliary use of outlier tests in investigations.